A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study-Reference-Cited by-同舟云学术

A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study

Published:2014-07-17 Issue:3 Volume:56 Page:801-804
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Martino Massimo,Russo Letteria,Martinello Tiziana,Gallo Giuseppe Alberto,Fedele Roberta,Moscato Tiziana,Console Giuseppe,Vincelli Donatella Iolanda,Ronco Francesca,Postorino Maurizio,Irrera Giuseppe,Messina Giuseppe

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.931952

Reference14 articles.

1. Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program

2. Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study

3. A comparison of inpatient and outpatient ASCT

4. Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic Malignancies

5. A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact;Frontiers in Immunology;2024-07-16

2. Optimizing autologous stem cell transplantation for multiple myeloma: early step-down ward vs. HEPA-filtered room settings – a practical approach for resource-constrained settings;2024-05-29

3. The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic;Supportive Care in Cancer;2023-05-25

4. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation;Annals of Hematology;2023-04-20

5. Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograft;Leukemia & Lymphoma;2023-04-20